NASDAQ : ALPS

Alps Group Inc

$0.4676 USD

$0.0 (0.3%)

Volume
36.6K
Average Volume
110.39K
Market Capitalization
$77.81M
P/E Ratio
-0.03
Dividend Yield
0.00%
Price Target
Year High
$2.90
Year Low
$0.45
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$0.04
Company Overview

NASDAQ

Seng Kong Tham

Biotechnology

Healthcare

ALPS

2

MY

USD

+1 603 216 31113

G0231P108

0002025774

Liquidity Metrics

-0.53

0.04

0.04

0.04

0.00

Sales & Valuation

$3.37M

23.08

-0.15

-114.31

-0.19

Profitability

-$14.64

-$67.57M

-2004.52%

-2000.04%

922.42%

-3884.16%

P/E Metrics

-0.03

0.00

0.00

Analyst Price Target & Rating

Sell

2/5

0 Analysts

%

Financial Health Scores

-137.84

3/9

-$8.55M

$1.74M

$12.97M

-$66.93M

Key Metrics (TTM)

$83.13M

24.66

-1.24

0.04

922.42%

5301.07%

-4120.55%

-0.88%

0 days

Company Executives

No executive data available.

Poll Results

No votes yet today — be the first to share your view!

About Alps Group Inc (NASDAQ:ALPS) Stock

Alps Group Inc. operates as a comprehensive biotechnology firm, delivering a wide array of services ranging from groundbreaking research and development to direct medical care and health optimization initiatives, with a primary focus on cutting-edge therapeutic solutions. The organization is committed to cultivating a just and balanced healthcare system, ensuring broad availability of early detection, disease prevention, and individualized treatment approaches. ...

ALPS Ties Fund Growth to Distribution Discipline

2026-07-24 15:06:36

Running a $22 billion ETF lineup with a distribution team far smaller than the largest issuers means every new fund has to earn its place on the shelf. Key Takeaways: A lean distribution team requires deliberate choices about new product launches.

Small Cap Quality Over Size: Why ALPS OUSM Deserves a Look

2026-06-24 15:47:17

When evaluating small-cap equity exposure, it's easy to gravitate towards the iShares Russell 2000 ETF (IWM) given its $82 billion in assets and 0.19% expense ratio. Yet, a closer look at another fund, the ALPS O'Shares U.S. Small-Cap Quality Dividend ETF (OUSM), reveals a fundamentally sound structural design that warrants closer attention.

Alps Group Inc Launches Patient-Derived Organoid Program to Advance Personalized Cancer Care in Southeast Asia

2026-06-23 08:05:00

Agreement Marks Company's Expansion into Precision Oncology Testing, with the Goal of Establishing Malaysia's First Clinically Validated PDO Platform Agreement Marks Company's Expansion into Precision Oncology Testing, with the Goal of Establishing Malaysia's First Clinically Validated PDO Platform

ETFs for Investors Seeking Balance Amid Ceasefire Optimism

2026-06-12 11:06:07

Markets rally on ceasefire hopes, but should investors chase the headlines? ETFs can offer a balanced approach in a headline-driven market.

Alps Group Inc Expands MyGenome Accreditation to Include Whole Genome Sequencing Under MS ISO 15189:2022

2026-06-09 08:05:00

MyGenome Joins a Limited Number of Southeast Asian Laboratories Delivering WGS Under Internationally Recognized Clinical Standards, Strengthening its Position in Southeast Asian Genomics MyGenome Joins a Limited Number of Southeast Asian Laboratories Delivering WGS Under Internationally Recognized Clinical Standards, Strengthening its Position in Southeast Asian Genomics

Love the AI Story but Hate the Concentration Risk? Consider ETFs

2026-06-02 11:46:07

AI is driving markets higher, but a handful of stocks are doing most of the heavy lifting. These ETFs offer a more balanced way to play the trend.

ALPS EQL Swaps SPDR ETFs for New VettaFi Index

2026-06-01 08:50:04

The ALPS Equal Sector Weight ETF (EQL) officially changes its underlying benchmark today, swapping out the NYSE Equal Sector Weight Index for the VettaFi Modelist Equal Weight Sector 500 Index (VFES500). Key Takeaways: EQL is switching to the VettaFi Modelist Equal Weight Sector 500 Index on June 1.

Tech-Heavy & Anxious? Pick ETFs to Diversify Beyond the AI Bet

2026-05-20 10:50:23

The AI trade continues to power markets, but rising concentration risks and volatile sentiment are making diversification increasingly important. Staying diversified with ETFs may be the smartest long-term move.

Frequently Asked Questions

What is the current Alps Group Inc (ALPS) stock price?

Alps Group Inc(NASDAQ:ALPS) stock price is $0.4676 in the last trading session. During the trading session, ALPS stock reached the peak price of $2.9 while $0.445 was the lowest point it dropped to. The percentage change in ALPS stock occurred in the recent session was 0.3% while the dollar amount for the price change in ALPS stock was $0.0.

ALPS's industry and sector of operation?

The NASDAQ listed ALPS is part of Biotechnology industry that operates in the broader Healthcare sector.

Who are the executives of ALPS?

|
|
|
|
|

How many employees does ALPS have?

Number of ALPS employees currently stands at 2. ALPS operates from Unit E-18-01 & E-18-02, Level 18, Icon Tower (East), No. 1, Jalan 1/68F, Off Jalan Tun Razak, Kuala Lumpur, WP 50400, MY.

Link for ALPS official website?

Official Website of ALPS is: https://alps-holdings.com

How do I contact ALPS?

ALPS could be contacted at phone #+1 603 216 31113 and can also be accessed through its website. ALPS operates from Unit E-18-01 & E-18-02, Level 18, Icon Tower (East), No. 1, Jalan 1/68F, Off Jalan Tun Razak, Kuala Lumpur, WP 50400, MY.

How many shares of ALPS are traded daily?

The average number of ALPS shares traded daily for last 3 months was 110.39K.

What is the market cap of ALPS currently?

The market value of ALPS currently stands at $77.81M with its latest stock price at $0.4676